10-Q: Bleichroeder Acquisition Corp. II Q1 2026 Financial Report
Quarterly Report
Bleichroeder Acquisition Corp. II reports Q1 2026 results while advancing its $2.0 billion business combination with Pasqal.
Summary
- Reported a net loss of $2,692,419 for the three months ended March 31, 2026.
- Completed an Initial Public Offering (IPO) on January 9, 2026, raising $287.5 million in gross proceeds.
- Entered into a definitive Business Combination Agreement with Pasqal Holding SAS on February 28, 2026, valuing Pasqal at $2.0 billion pre-money.
- Secured a $250 million private placement investment (convertible bonds and warrants) to support the business combination.
- Maintains $289.7 million in a Trust Account as of March 31, 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral-to-positive development; while the company faces going-concern risks typical of a SPAC, the successful signing of a definitive merger agreement with a high-profile target like Pasqal and the securing of significant PIPE financing are positive indicators.
Positives
- Successfully completed IPO and over-allotment option, raising $287.5 million.
- Entered into a definitive merger agreement with Pasqal, a quantum computing company.
- Secured $250 million in additional private placement financing to support the transaction.
- Maintains strong liquidity in the Trust Account to facilitate the business combination.
Negatives
- Reported a net loss of $2.69 million for the quarter.
- Working capital deficit of $2,930,576 as of March 31, 2026.
- Incurred significant transaction costs of $17.87 million related to the IPO.
Risks
- Substantial doubt regarding the ability to continue as a going concern if the business combination is not completed.
- Dependence on the successful completion of the Pasqal business combination.
- Potential for redemption of public shares, which could reduce the cash available for the business combination.
- Geopolitical instability and market volatility could adversely affect the search for or completion of a business combination.
- The Sponsor may not have sufficient funds to satisfy indemnity obligations.
Future Outlook
The company is focused on completing the business combination with Pasqal by the end of the Completion Window. The transaction is subject to customary closing conditions, including shareholder approval and regulatory clearances.
Management Comments
- Management believes the Pasqal business combination represents a significant opportunity in the disruptive growth sector.
- Management acknowledges the liquidity condition raises substantial doubt about the ability to continue as a going concern.
Industry Context
StockSavvy.ai notes that this filing reflects the typical lifecycle of a Special Purpose Acquisition Company (SPAC) that has successfully identified a target in the high-growth quantum computing sector, a trend currently seeing increased interest from institutional investors despite broader market volatility.
Comparison to Industry Standards
- The $2.0 billion valuation for Pasqal is consistent with recent high-profile SPAC mergers in the deep-tech and quantum computing sectors.
- The use of a private placement (PIPE) to secure $250 million is a standard mechanism to ensure minimum cash requirements are met for SPAC mergers.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Chairman | N/A | Andrew Gundlach | 2026-04-29 | Management restructuring |
| Chief Executive Officer | Andrew Gundlach | Marcello Padula | 2026-04-29 | Management restructuring |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Appointment | Appointment of Philippe Nyssen and Clemence Rasigni as independent directors. | 2026-02-10 | Strengthens board independence and audit committee oversight. |
Legal Proceedings
- None reported.
Related Party Transactions
- Sponsor provided initial capital and loans for formation and IPO expenses.
- Advisory agreement with an affiliate of the COO for $18,000 per month.
Stakeholder Impact
- Shareholders are subject to the risks associated with the pending business combination.
- Potential dilution for existing shareholders upon conversion of warrants and convertible bonds.
Next Steps
- Obtain shareholder approval for the business combination.
- File a registration statement on Form F-4 with the SEC.
- Satisfy all closing conditions, including regulatory approvals.
- Complete the business combination by the end of the Completion Window.
Key Dates
| Date | Description |
|---|---|
| 2025-08-27 | Incorporation of Bleichroeder Acquisition Corp. II |
| 2025-09-22 | Issuance of founder shares to Sponsor |
| 2026-01-07 | Registration statement for IPO declared effective |
| 2026-01-09 | Consummation of IPO and over-allotment option |
| 2026-02-28 | Signing of Business Combination Agreement with Pasqal |
| 2026-03-31 | Quarterly period end |
| 2026-05-07 | Filing date of Form 10-Q |
Recommendation
holdInvestors should maintain a hold position pending the completion of the business combination, as the stock's value is now primarily tied to the successful merger with Pasqal and the associated regulatory and shareholder approval processes.
Keywords
SPAC, Bleichroeder Acquisition Corp. II, Pasqal, Business Combination, Quantum Computing, IPO, 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.